Hatteras Venture Partners — Full Portfolio

AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.

BiotechHealthtechMenlo Park, US

Joseph S. Zakrzewski(Co-Founder & Director)EEEric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)SCSanjay Chanda(Chief Development Officer)inLOLucy O. Day(Chief Financial Officer)in

Co-investorsADAdjuvant CapitalBIBioRock VenturesFLFlucas VenturesMOMountain Group CapitalRARA CapitalBIBiotechnology Value Fund

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

BiotechHealthtechMedical DevicesAustin, US

CPCraig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)KHKevin Hykes(President, Chief Executive Officer & Director)in

Co-investorsABABS VenturesNENew Enterprise Associates (NEA)TRTreo Ventures, LlcWIWindham Capital PartnersYSYsios CapitalACAction Potential Venture Capital Ltd.+1 more

Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.

BiotechDeep TechHealthtech

NMNello Mainolfi(Founder)inBBBruce Booth(Chair)in

Co-investorsATAtlas VentureAVAvoro Capital AdvisorsBABain Capital Life SciencesBEBessemer Venture PartnersMRMRL Ventures FundNENextech Invest+7 more

Shattuck Labs is a biotechnology company developing biologic medicines targeting TNF receptors, including the TL1A/DR3 axis, for patients with cancer and inflammatory or life-altering diseases.

BiotechHealthtechAustin, US

JHJosiah Hornblower(President/CEO)inTaylor(Co-founder & Chief Executive Officer, Board Member)

BoardWalter Loewenbaum(Director)

Co-investorsECEcoR1 CapitalOROrbiMedRORocky Point VenturesREREDMILET.T. Rowe Price

A biotech company offering gene expression analysis tools for blood-based biomarker detection across multiple cancer types.

BiotechDigital HealthMedical DevicesDurham, US

CMCharles M. Perou(Founder and Director)inMMMICHAEL MILBURN(Executive Officer, Director)inDavid Neil Hayes(Executive Officer, Director)

BoardArnold Levine(Director)

Board seatMLMyla Lai-GoldmanClay Thorp· per SEC Form D

Co-investorsIAIAG Capital Partners

Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.

BiotechDigital HealthChapel Hill, US

Jenny Ting(Director and Co-founder)Matthew Cohen(Director)Lev Osherovich(Director)Mark Vellaca(Director)Anil Goyal(CEO and Director)

BoardBenjamin Scruggs(Director)

Board seatMVMark Velleca· per SEC Form D

Co-investorsDEDelin VenturesOUOUP (Osage University Partners)

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.

BiotechHealthtechMedical DevicesRaleigh, US

Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)JFJohn Fahy(Director)in

BoardCSChristy Shaffer(Director)inRGRishi Gupta(Director)inTSTim Shannon(Director)in

Co-investorsOROrbiMedCACanaan PartnersPAPappas Capital

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

LELynn Elliott(Co-Founder)MJMudit Jain(Co-Founder)PMPaul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)KPKetan Patel(Director)in

Co-investorsTRTreo Ventures, LlcF-F-Prime Capital

Boomerang Medical develops a bioelectric neuromodulation device to treat bowel urgency symptoms in patients with ulcerative colitis and other inflammatory bowel disease.

BiotechDigital HealthMedical DevicesMountain View, US

Co-investorsARArboretum Ventures

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.

HardwareHealthtechMedical DevicesRaleigh, US

RSRavish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)

Co-investorsLILightstone VenturesAMAmzak HealthMOMountain Group CapitalUSUS Venture Partners

iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases.

BiotechHealthtechMedical DevicesMinneapolis, US

MKMudit K. Jain(Co-Founder and Chairman of the Board)LELynn Elliott(Co-Founder and Director)inSMSteve Masson(President & CEO)in

Co-investorsTRTreo Ventures, LlcF-F-Prime Capital

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

DEDavid Eveleth(Executive Officer, Director)inSNSchalon Newton(Executive Officer)in

BoardCSChristy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsEXExSight VenturesSOSolasta VenturesACAccess BiotechnologyBIBios PartnersCOCorrelation VenturesFEFemHealth Ventures+1 more

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.

AI & Machine LearningDigital HealthHealthtechBranford, US

Joshua Ransom(Executive Officer)DLDavid Levin(Chief Executive Officer)inJBJosh Brown(Chief Technology Officer)inSCScott Caflisch(Chief Information Security Officer)inJGJeff Graham(Chief Data Officer)inJSJennifer Stacey(Chief Operating Officer)in

Board seatJCJohn Crumpler· per SEC Form D

Co-investorsCOConnecticut InnovationsEXExcelerate Health VenturesMAMartin VenturesBOBoston Millennia PartnersSOSopris Venture Capital

Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.

AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US

AGAmit Gupta(Co-founder, Advisor)inMEMozziyar Etemadi(Co-founder, Head of AI)OIOmer Inan(Co-founder, Chief Scientific Officer)inACAndrew Carek(Co-founder, Chief Technical Officer)inEMEric Meizlish(Chief Executive Officer)inJDJohn D. Martin(Chief Medical Officer)in

Board seatLPLauren P. Flickinger· per SEC Form D

Co-investorsBABayMed Venture PartnersBRBroadview VenturesCRCross-Border Impact VenturesLALaerdal Million Lives FundOSOSF VenturesPOPortal Innovations+1 more

Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.

BiotechHealthtechMedical DevicesAlpharetta, US

Mark Prausnitz(Director)inCharles Deignan(Executive Officer)GNGlenn Noronha(Executive Officer)inDHDaniel H. White(Executive Officer, Director)in

BoardEvgeny Zaytsev(Director)DYDerek Yoon(Director)in

Board seatCBClay B. ThorpCSChristy Shaffer· per SEC Form D

Co-investorsHEHEALTHCARE ROYALTY PARTNERSMOMountain Group CapitalSOSolasta VenturesHAHatteras

Healthcare-enabling research organization that embeds clinical trials into everyday care using electronic health record data.

HealthtechAustin, US

Chad Moore(Founder)inJPJohn Potthoff(Founder)inJBJacylyn Bodmer(Chief Information Officer)KFKaren Flaherty(Vice President, Finance)inASAmy Staedtler(Chief Legal Officer)inSTScott Treiber(Chief Operating Officer)in

Board seatJCJohn Crumpler· per SEC Form D

Co-investorsEXExcelerate Health VenturesNONoro-Moseley PartnersNONorwest Venture PartnersSHShumway CapitalALAlly Bridge Group

G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.

BiotechResearch Triangle Park, US

Jay Strum(Executive Officer)NSNorman Sharpless(Director)MAMark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)

Board seatCBClay B. ThorpCSChristy Shaffer· per SEC Form D

Co-investorsLULumira VenturesMOMountain Group CapitalRARA CapitalSOSolasta Ventures

Qoniq combines tailored AI analytics with expert guidance to help Medical Affairs and Scientific Affairs teams analyze large volumes of publications and datasets, surface patterns, and generate industry-standard, well-sourced scientific reports.

AI & Machine LearningBiotechHealthtechPalo Alto, US

Gregory Kostello(Executive Officer)Lana Feng(Executive Officer, Director)inSusan Shiff(Executive Officer, Director)inWilliam Dai(Director)

BoardAndrew Schwab(Director)

Board seatJohn Crumpler· per SEC Form D

Co-investorsFUFusionPHPharmStars VenturesRERealization Capital PartnersSTSteelSky VenturesJLJLL Spark Global VenturesNOnoa

ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology.

AI & Machine LearningDigital HealthHealthtechMental HealthSaaSFairview, US

MTMark Tuomenoksa(Co-Founder & Chief Technology Officer)inLPLauren Pierce Flickinger(Chief Executive Officer)inKate Rahimzadeh(Chief Operating Officer)inSandeep Goel(Executive Officer, Director, Promoter)

Board seatLPLauren P. Flickinger· per SEC Form D

Co-investorsHOHomebrewHEHealth Catalyst Capital

Pelthos Therapeutics is a biopharmaceutical company that develops and commercializes topical treatments for infectious skin conditions and parasitic infestations.

BiotechHealthtechMedical DevicesDurham, US

Mark Schoenfisch(Executive Officer, Director)Nathan Stasko(Executive Officer, Director)

BoardRobert A Ingram(Director)Sean Murphy(Director)W Kent Geer(Director)John W Palmour(Director)

Board seatRobert Ingram· per SEC Form D · $50M raise · filed Mar 2015

PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.

BiotechHealthtechMedical DevicesMalvern, US

Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)JMJonathan Mow(Chief Executive Officer)in

BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)

Board seatRobert IngramCBClay B. Thorp· per SEC Form D

Co-investorsMOMountain Group CapitalNENew Enterprise Associates (NEA)JOJohnson & Johnson Innovation – JJDC

StrideBio develops gene therapies based on its STRIVE AAV capsid platform, targeting people with life-threatening diseases.

BiotechHealthtechDurham, US

AAAravind Asokan(Director)inMAMavis Abjandje-McKenna(Director)RSRichard Smith(Executive Officer)inPatrick Ritschel(Executive Officer, Director, Promoter)

Board seatClay ThorpMike Dial· per SEC Form D

Co-investorsPOPontifax Venture CapitalABAbingworthDEDe Novo VenturesNONorthpond Ventures

An R&D-driven biopharmaceutical company that uses AI to develop breakthrough medicines and vaccines focused on immune system disorders across five therapeutic areas.

AI & Machine LearningBiotechMedical DevicesCambridge, US

IMIvana Magovcevic-Liebisch(Executive Officer, Director)CVChristopher Verni(Executive Officer)inMary Thistle(Director)Evan Thackaberry(Executive Officer)Suzanne Bruhn(Director)Gerhard Koenig(Director)

Board seatClay Thorp· per SEC Form D

Co-investorsATAtlas VentureLILightstone VenturesPIPivotal Life SciencesVIVida VenturesLOLongwood Fund

Wildflower Health offers a modular suite of software and services for women's health, combining a digital patient engagement app, a national network of human health advocates and specialists, and value-based care payment model support.

Digital HealthFemTechHealthtechSan Francisco, US

LSLeah Sparks(CEO & Founder)inKim Russell(Chief Financial Officer of Issuer)in

BoardDGDan Galles(Director of Issuer)inEzra Mehlman(Director of Issuer)RSRalph Sabin(Director of Issuer)in

Board seatJohn Crumpler· per SEC Form D

Co-investorsALAllumia VenturesECEcho Health VenturesHEHealthtech CapitalRORock Health Capital

410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.

HardwareHealthtechMedical DevicesDurham, US

Mark Donald Piehl(Executive Officer, Director)KCKYLE CHENET(Executive Officer, Director)in

BoardJTJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FGFRED GOLDWATER(Director)inMAYANK TANEJA(Director)in

Co-investorsBABallad VenturesCUCU Healthcare Innovation FundDUDuke Capital PartnersOSOSF VenturesWEWellstarWOWolfpack Investor Network+2 more

Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.

BiotechDeep TechHealthtechMedical DevicesDurham, US

Christopher Sims(Executive Officer)inJimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)

BoardChristopher Perkins(Director)

Co-investorsATAtlanta Technology AngelsCECentral Texas Angel NetworkCHCheckmate Capital Group LLCCOCowtown AngelsJOJohnson Venture PartnersNCNC IDEA+1 more

AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.

HardwareHealthtechMedical Devices

Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)

Co-investorsARArboretum VenturesBABayMed Venture PartnersBRBroadview VenturesCACatalyst Health Ventures

Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss.

BiotechDeep TechMedical DevicesAustin, US

Co-investorsLILightstone VenturesWEWellington ManagementSOSofinnova Ventures

Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.

BiotechDeep TechBoston, US

SVShane V. Hegarty(Chief Scientific Officer & Co-Founder)inJSJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJIJeff Imbaro(Chief Operating Officer)inTSTiasha Shafiq(Chief of Staff)in

BoardC.Corey . Goodman(Director)inJLJonathan Leff(Director)in

Co-investorsSOSofinnova VenturesVEvenBio PartnersMRMRL Ventures FundCICivilization Ventures Management, LlcCRCreative Destruction Lab (CDL)IAIaso Ventures+8 more

Backrs provides personalized coaching and college and career planning to help students—particularly high-performing, under-resourced young people—choose schools, majors, and career paths based on real outcomes like earnings and job placement.

ConsumerEdTechImpact & Social GoodSan Francisco, US

ABAndy Bobowski(Founder)in

Co-investorsCICity Light

HealthtechBurlington, US

AAArtur Adib(CEO)inTim Wall(Director)

Co-investorsBRBreyer CapitalDUDudley FundY Y Combinator191984 Ventures Management, LlcALAltaclub VCALAltaIR Capital+6 more

Boston Immune Tech develops immunotherapies for treatment of infectious diseases and cancer.

BiotechHealthtechMedical DevicesBoston, US

Russell LaMontagne(Chief Executive Officer)inDavid Brooks(Chief Medical Officer)in

Caidya provides clinical trial management solutions designed for pharmaceutical and biotech companies seeking to improve trial efficiency and patient outcomes through integrated, patient-centric approaches.

BiotechDigital HealthHealthtech

BLBarbara Lopez Kunz(Chief Executive Officer)inMCMichael Clay(Chief Operating Officer)inSMSharon Moore(Chief Medical Officer)inBPBrandon Pallott(Chief Commercial Officer)inMLMiron Lila(Chief Corporate Development Officer)inJSJohn Scott(Chief Information Officer)in

Co-investorsQIQiming Venture PartnersVIVivo Capital

Based in Research Triangle Park, NC

BiotechResearch Triangle Park, US

LCLucinda Camras(Executive Officer, Director, Promoter)inRoberto Alfaro(Executive Officer, Director)Ray Krauss(Executive Officer, Director)

BoardRobert Rothman(Director)

Co-investorsCHCharlotte Angel FundINInFocus Capital Partners, LLCVCVCapital

Canopy Lawn Care provides science-based residential lawn care services using natural ingredients like coffee grounds, amino acids, probiotics, and sea kelp to promote soil health and reduce reliance on synthetic fertilizers and pesticides.

AgTechCleantechConsumer

Co-investorsELElevate Innovation PartnersACACME CapitalARArrington CapitalBOBorderless CapitalFEFenbushi CapitalNYNyca Partners+2 more

HealthtechChicago, US

SCShara Cohen(President and CEO)inMARIA PERRIN(Director)

BoardJBJohn Banta(Director)inTJTodd Johnson(Director)ECEmma Cartmell(Director)in

Co-investors41412 Venture FundCACartmell VenturesFCFCA Venture PartnersLOLOUD CapitalBLBlueCross BlueShield Venture PartnersCRCREATE HEALTH VENTURES+1 more

Carpe manufactures clinical-grade antiperspirant and skincare products designed to reduce underarm sweat and odor for consumers.

ConsumerDirect to ConsumerHealthtechWellness & Fitness

Co-investorsLALaunchCapital

Caidya is a contract research organization (CRO) that provides scientific, medical, and operational support for clinical development and cross-border clinical trials.

BiotechDigital HealthHealthtechMorrisville, US

Mark Ubert(Executive Officer)Jesse Watson(Director)Brian Carney(Director)Jeff L. Williams(Executive Officer, Director)Melissa Daniels(Director)Christopher K. Porter(Executive Officer)

Co-investorsCRCreathor VenturesOUOUP (Osage University Partners)

Clinverse was a Durham, NC-based fintech company that automated financial management for global clinical trials, including site payments, budgeting, and currency conversion via its ClinPay platform.

Durham, US

Joseph F. Trepanier(Executive Officer)M. Denis Connaghan(Executive Officer, Director)in

BoardJCJohn Crumpler(Director)inAndy Strayer(Director)Kenneth B. Lee(Director)inNathaniel C. Brinn(Director)

Co-investorsEDEdison Partners

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.

BiotechDeep TechHealthtechHatfield, US

Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)BMBrian McVeigh(Executive Officer, Director)in

BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)

Co-investorsNENew Enterprise Associates (NEA)4B4BIO CapitalAMAmgen VenturesJDJDRF T1D FundNONorthpond VenturesTATakeda Ventures+1 more

Configo Health (Vircho) offers a platform for community-based organizations (CBOs) and payers to manage social care service delivery, covering compliance reporting, financial oversight, quality benchmarking, and network-level analytics.

Digital HealthHealthtechSaaS

Curoverse provides solutions built on Arvados, an open source computing platform for managing and processing large-scale data from terabytes to petabytes.

Cloud ComputingData & InfrastructureDeep TechBoston, US

Ward Vandewege(Executive Officer)Alexander Wait Zaranek(Director)Adam Berrey(Executive Officer, Director)

BoardMichael Dial(Director)David Martirano(Director)

Co-investorsHYHyperplane Venture Capital

Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases.

BiotechHealthtechDurham, US

Robin Hyde-DeRuyscher(Founder)inMKMoise Khayrallah(CEO)inMargaret Powell(Director)Robert Helmedag(Director)John E. Bailey, Jr.(Director)

Co-investorsRERex Health VenturesWOWolfpack Investor NetworkVEVentureSouth

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes.

Digital HealthHealthtechMedical DevicesMinneapolis, US

SPStacey Pugh(Leadership (CEO))inChris Sorli, MD, PhD(Chief Medical Officer)inKrissy Wright(Chief Financial Officer)inLian Cunningham, MD, PhD(VP Clinical Affairs)inMHMelanie Hess(Regulatory Affairs Leadership)inMCMatt Cambronne(Technical/Engineering Leadership)in

Co-investorsARArboretum VenturesINIntuitive VenturesLOLongitude CapitalLULumira VenturesSOSoutheast Minnesota Capital Fund

Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics.

BiotechDefense TechHealthtechMedical DevicesDurham, US

Bert Valada(President and CEO)inRichard Martin(Executive Officer)Susan Reyer(Executive Officer)Michael Galiger(Executive Officer)John Mowell(Director)Thomas Edwards(Director)

FilterEasy is an online retailer that sells home air filters directly to consumers, with a focus on delivery and subscription-based replacement.

ConsumerDirect to ConsumerE-commerceRaleigh, US

Thaddeus W. Tarkington(Executive Officer, Director)KJKevin J. Barry(Executive Officer, Director)in

BoardSDSteve Dauphin(Director)DEDavid E. Gardner(Director)inLDLister Delgado(Director)inTom Lotrecchiano(Director)

Co-investorsAZAzure Capital PartnersCOCofounders CapitalELElevate Innovation PartnersMOModerne VenturesARArsenalARArsenal Growth Equity+4 more

An operating system enabling real estate agents to win more business

Co-investorsELElevate Innovation Partners

GoCheck Kids offers a smartphone-based MultiScreener that combines photoscreening, visual acuity, and pure tone audiometry to screen young children for vision and hearing problems.

Digital HealthHealthtechMedical Devices

DHDavid Huang(Founder)in

Co-investorsALAloft VCFCFCA Venture PartnersMUMucker Capital

Gozio provides a mobile-first platform that helps health systems build patient-facing apps for navigating care, including indoor wayfinding and patient engagement.

Digital HealthHealthtechSaaSAtlanta, US

JTJoshua Titus(Executive Officer, Director)DKDennis Keller(Executive Officer, Director)inKLKevin Lee(Executive Officer, Director)in

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients.

BiotechHardwareHealthtechMedical DevicesAnn Arbor, GB

TDThomas Davison(Executive Officer, Director)inMCM. Christine Gibbons(Executive Officer, Director)inWen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)

Co-investorsALAlpha JWC VenturesALAlpha Wave GlobalAMAmzak HealthARArboretum VenturesCLClarevia VenturesEAEarly Stage Partners, LP+8 more

Improved Nature produces plant-based protein products made from sustainably sourced non-GMO soy, targeting consumers seeking healthier and more environmentally responsible food options.

FoodTechHealthtechImpact & Social GoodGarner, US

Richard R. Hawkins(President/CEO)

BoardMoshe Meidan(Manager)Ken Campbell(Manager)Sarid M. Shefet(Manager)

Co-investorsWOWolfpack Investor NetworkCOConcentric

Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.

BiotechHealthtechDurham, US

PRPatrick Roberts(Executive Officer and member of the Board of Managers.)in

BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)

Co-investorsCACape Fear BioCapitalESEshelman Ventures, LLCHAHatteras

InnAVasc develops a vascular access graft for hemodialysis, featuring self-sealing pods and puncture-resistant backplates that guide dialysis needle placement to reduce needle-injury and bleeding complications.

BiotechHardwareHealthtechMedical DevicesDurham, US

Shawn Gage(Executive Officer)Jeffrey Lawson(Executive Officer, Director)Joseph Knight(Executive Officer, Director)Roberto Duane Manson(Executive Officer)

BoardDani Bolognesi(Director)

Co-investorsARArieal Southeast Angel PartnersDUDuke Capital Partners

InvestorFlow provides an integrated front office platform for private markets firms, connecting capital formation, deployment, asset management, and investor services workflows in real time.

AI & Machine LearningEnterprise SoftwareFintechSaaS

Chris Ashrafi(Chief Revenue Officer)in

Co-investorsAMAmbina PartnersGRGrandBanks CapitalKPKPS Capital PartnersMEMerit Capital PartnersRERelay InvestmentsSTSteelSky Ventures

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.

Deep TechHealthtechMedical DevicesRoseville, US

TKTodd Kerkow(Co-Founder, President and CEO)inMJMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)

BoardKNKirk Nielsen(Director)in

Co-investorsTRTreo Ventures, LlcVEVensana Capital

Jumo Health provides patient experience solutions for clinical trials, focusing on building patient readiness through education and behavioral systems rather than traditional recruitment.

Digital HealthHealthtech

Co-investorsEXExcelerate Health VenturesFAFalfurrias

KWIPPED is an online marketplace that connects businesses and institutions seeking to rent or buy equipment with suppliers across categories such as medical, lab, audiovisual, and industrial equipment.

B2B MarketplacesE-commerceFintechWilmington, US

Robert B Preville(Executive Officer, Director)Robert Kaiser(Executive Officer, Director)

BoardRandy Swartz(Director)

Co-investorsVEVentureSouth

Ladder Health provides digital health services focused on pediatric care and developmental screening, helping families navigate healthcare options for their children.

Digital HealthHealthtechBoston, US

EKElizabeth Kidderin

Co-investors2525MadisonGRGROOVE CAPITALJUJumpstart CapitalMAMairs & Power VCNINina CapitalCRCREATE HEALTH VENTURES

Lysosomal Therapeutics Inc.

BiotechCambridge, US

Dimitri Krainc(Director)Robert Carpenter(Executive Officer, Director)Cornelis Been(Executive Officer, Director)

BoardSteven Hall(Director)Carole Nuechterlein(Director)inBernard Davitian(Director)

Co-investorsSASanofi VenturesATAtlas VentureLILilly VenturesOMOmega FundsRORoche Venture Fund

Melo Creative is a website design studio offering minimalist Showit website design and SEO strategy services for photographers and small business creatives.

Creator EconomyMarketing Tech

Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.

BiotechDigital HealthHealthtechMedical DevicesNatick, US

Paul Blavin(Co-Founder & Vice Chairman)inSLStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)

BoardPMPaul Meister(Director)SHSonja Hoel Perkins(Director)in

Co-investorsAVAvestria VenturesISiSelect FundMIMindshift CapitalNONovalis LifeSciencesPOPortfoliaSOSozo Ventures+2 more

CREATE Medicines develops in vivo CAR immunotherapy using proprietary mRNA-LNP technology to program T cells, NK cells, and myeloid cells directly within the body for cancer, autoimmunity, and fibrosis.

AI & Machine LearningBiotechHealthtechMedical DevicesCambridge, US

DGDaniel Getts, Ph.D.(Chief Executive Officer, Cofounder, Board Director)

Co-investorsARARCH Venture Partners8V8VCALAlexandriaNENewpath Partners

HealthStream's Nursegrid Unlimited CE is a subscription service offering nurses unlimited access to continuing education courses that meet state-specific regulatory requirements for nursing practice compliance.

ConsumerDigital HealthEdTechFuture of WorkHealthtechHR TechSaaS

Co-investorsEXExcelerate Health VenturesPOPortland Seed FundTOToba CapitalARArboretum VenturesHEHEALTHBOX

NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension.

BiotechHealthtechLongevityNashville, US

MZMichael Zemel(Executive Officer, Director)BCBarbara Cannon(Executive Officer)Joseph C. Cook, Jr.(Executive Officer, Director)

BoardEric Satz(Director)Vaughn Bryson(Director)Brian Laden(Director)

Co-investorsMOMountain Group Capital

Orbital RX provides a software platform for hospital pharmacy supply chain management that integrates inventory tracking, procurement workflows, and real-time team collaboration to coordinate shortage response across healthcare networks.

AI & Machine LearningEnterprise SoftwareHealthtechSaaS

NPNate Peaty(Founder)in

Co-investorsALAlerion VenturesEXExcelerate Health VenturesTHThe Launch Place

Perfuse Therapeutics develops novel ocular therapies for retinal and glaucoma diseases through drug delivery and formulation platforms.

BiotechHealthtechMedical DevicesSan Francisco, US

SGSevgi Gurkan(Founder, Chief Executive Officer, and Member of the Board of Directors)in

BoardChristy Shaffer(Director)Chau Khuong(Director)in

Co-investorsOROrbiMedACAccess BiotechnologyCACatalio Capital Management, LPLALAVLILilly Asia VenturesHAHatteras

Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid.

BiotechDeep TechHealthtechMedical Devices

Mark Wagner(Founder, Investor, & Director in Pharaoh)inDr. Nandan Lad(Chief Medical Officer & Co-Founder)Rich Nazarian(Founder, Investor, & Director in Pharaoh)inARAmaza Reitmeier(Chief Executive Officer, Director)in

Co-investorsARArboretum VenturesIAIAG Capital PartnersLALaerdal Million Lives Fund

Pryon provides a memory layer platform that helps enterprises move AI projects into production by ingesting, governing, and securing content across multiple formats and sources.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSRaleigh, US

JD Vance(Director)Igor Jablokov(Founder)

Co-investors7B7BC Venture CapitalAPAperture Venture CapitalCRCrosscourt VenturesDUDuke Capital PartnersGAGaingelsGOGood Growth Capital+11 more

QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria.

BiotechHealthtechSan Diego, US

MNMichael N. Dudley(Executive Officer, Director)inTerry Gould(Director)Daniel Burgess(Director)

BoardCGCarol Gallagher(Director)inDRDouglas Reed(Director)inKLKevin Li(Director)in

Co-investorsLYLYZZ CapitalNENew Enterprise Associates (NEA)ADAdams Street Partners

RapidPulse Medical is an investor relations page showcasing multiple healthcare-focused investment firms and incubators that back medical device and healthcare technology companies.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsBRBroadview VenturesEPEpidarex CapitalFLFlorida Opportunity FundS3S3 VenturesSASante Ventures

restor3d designs and manufactures patient-specific 3D-printed orthopaedic implants for musculoskeletal reconstruction, using osseointegrative biomaterials, AI-driven design, and digital health tools.

AI & Machine LearningDigital HealthHealthtechMedical DevicesDurham, US

CKCambre Kelly(Executive Officer)inKenneth Gall(Executive Officer, Director)KJKurt Jacobus(Executive Officer, Director)inAMAndrew Miller(Executive Officer)Michael Fillion(Executive Officer)GAGreg Anglum(Executive Officer)in

Co-investorsDUDuke Capital Partners

BiotechGreenville, US

KWKevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Co-investorsILIllumina VenturesM M VenturesMCMC Healthcare VenturesPAPappas CapitalSVSV Health InvestorsABAbbVie+2 more

HealthtechCambridge, US

Adam Rosenberg(Executive Officer, Director)inAMAnkit Mahadevia(Founder)in

BoardBBBruce Booth(Director)inKees Been(Director)Samantha Singer(Director)

Co-investorsGVGV (Google Ventures)THThird Point VenturesATAtlas VentureJJJJDCRERemeditex Ventures

Roobrik provides science-based online surveys, financial-readiness assessments, and chat tools that help prospective senior living residents and their families evaluate their options while converting more website visitors into qualified leads for senior living providers.

Digital HealthHealthtechMarketing TechSaaSSales TechGreensboro, US

NONate O'Keefe(Founder)inJudith Conaway(Executive Officer)DLDavid Levin(Director)inMaureen O'Connor(Director)William Clark(Director)

Co-investorsJUJurassic CapitalNCNC IDEATHThe Launch PlaceTHThird Act Ventures

Rx Redefined provides a platform and management services for DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies) ordering, handling revenue cycle processes, compliance checks, and audit processing for physicians.

BiotechDigital HealthHealthtechMedical DevicesSaaSArroyo Grande, US

BBBrandon Boots(Founder & CEO)inErik Smith(Executive Officer, Director)

BoardICIan Chiang(Director)inRCRoger Chen(Director)in

Co-investorsCRCrosscut VenturesFLFlare Capital PartnersSISilverton PartnersTUTusk Venture PartnersNENew Enterprise Associates (NEA)SASaturn Five

SafeRide Health provides non-emergency medical transportation (NEMT) through a technology platform and a nationwide network of transport and rideshare providers, connecting patients — largely Medicare Advantage and Medicaid members — to healthcare appointments.

Digital HealthHealthtechMobility & Transportation

RSRobbins Schrader(Chief Executive Officer, Co-Founder)BSBen Salter(Chief Product Officer, Co-Founder)inWSWhit Schrader(VP of Ops Transformation, Co-Founder)in

Co-investorsAMAmplify.LABOBonfire VenturesFCFCA Venture PartnersFRFresenius Medical Care VenturesHDHDS CapitalLALayout Ventures+5 more

Sailthru is a cross-channel marketing platform that lets brands run personalized email, SMS, mobile push, in-app, and web campaigns using AI-driven unified customer profiles.

AI & Machine LearningMarketing TechSaaSNew York, US

NCNeil Capel(Co-founder, Chief Executive Officer; later Chairman)IWIan White(Co-founder and Chief Technology Officer)inChris Chapman(Co-founder / engineering leader)ASAmy Shapero(Chief Financial Officer)NLNeil Lustig(Chief Executive Officer)in

BoardSBStacey Bishop(Board Director (Scale Venture Partners))in

Co-investorsBOBowery CapitalLELerer HippeauRRRRE VenturesRURunway Venture PartnersSCScale Venture PartnersTHThrive Capital+2 more

Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.

AI & Machine LearningBiotechDigital HealthMedford, US

JRJerrold Rosenbaum(Director)inJHJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)

BoardRKRyan Katz(Director)inKLKevin Lalande(Director)inRichard Simon(Director)

Co-investorsBOBonaventure Equity, LLCDODolby Family VenturesITIter InvestmentsMIMission BiocapitalPAPalo Santo VCRORoute 66 Ventures+4 more

SportsEngine provides technology for youth sports organizations to manage team scheduling, registration, payments, communication, live streaming, and tournaments.

ConsumerSaaSSports TechRaleigh, US

Paul Dorney(Executive Officer)Brendan Szulik(Executive Officer, Director, Promoter)John Lambert(Executive Officer, Director, Promoter)Daniel Caldwell(Executive Officer, Director, Promoter)

BoardMatthew Szulik(Director)

Co-investorsIDIDEA Fund Partners

BiotechResearch Triangle Park, US

Andrew Jordan(Executive Officer, Director)John Taylor(Executive Officer, Director, Promoter)Robert Tarran(Director)

BoardDonald Rose(Director)

Co-investors5A5AM VenturesCACanaan Partners

Standard Bariatrics develops the Titan SGS™ Stapler, a specialized surgical device designed for sleeve gastrectomy procedures that creates consistent and symmetrical gastric pouches using an anatomy-based approach.

Medical Devices

Co-investorsARArieal Southeast Angel PartnersCICincyTechEMEmergent Medical Partners, LLPJOJobsOhio VenturesRCRC CapitalRIRiverVest Venture Partners+2 more

Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief.

BiotechDigital HealthMedical DevicesAlpharetta, US

Shyamy Sastry(Executive Officer, Director)

BoardDoug Reed(Director)Robert Crutchfield(Executive Officer, Director)AWAnita Watkins(Director)inKurt Jacobus(Director)in

Co-investorsPOPortal Innovations

Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.

AI & Machine LearningBiotechDeep TechDurham, US

MAMark A. Hallen(Founder & CTO)inMFMarcel Frenkel(Founder & CEO)inDPDamien Petty(Director)inJia Wei Xu(Director)Bruce Donald, PhD(Founder & Chair SAB)

Co-investorsCACape Fear BioCapitalDFDFJ DragonFundDRDraper AssociatesDUDuke Capital PartnersSOSOSVABAbbVie+4 more

Raleigh, US

Scott Bolin(Executive Officer, Director)Christopher Evans(Executive Officer, Director)

BoardTom Darden(Director)Kenneth Bowdon(Director)

Co-investorsINIndaco Venture PartnersWOWolfpack Investor NetworkBLBlue Hill Group Tethis

ThreatSwitch offers a compliance management platform that automates workflows such as travel requests, new hire onboarding, and security training, and centralizes task management, data tracking, and reporting in a shared workspace.

Enterprise SoftwareGovTechSaaSCharlotte, US

JMJohn M Dillard(Executive Officer, Director)in

Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.

BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US

AMAkira Matsuno(Co-Founder, President, CFO, COO)inDJDerek Jantz(Executive Officer)inCGCharles Gersbach(Co-Founder)inJMJohn McHutchison(CEO, Chairman of the Board)inDMDan McHugh(Co-Founder, Investor)inBSBlythe Sather(Executive Officer)in

Co-investorsDUDuke Capital PartnersMIMission BiocapitalNENew Enterprise Associates (NEA)PAPappas CapitalRVRV Invest GmbHSASaisei Ventures+2 more

Durham, US

Jesko von Windheim(Executive Officer, Director)Richard N. Scott(Executive Officer)Timothy S. Tracey(Executive Officer, Director)Jill Marcotte(Director)Matt Bittner(Director)

Co-investorsDUDuke Capital Partners

Developing novel treatments based on the 12-LOX pathway for immuno-inflammatory diseases.

Co-investorsALAlumni VenturesPAPappas CapitalSASanofi VenturesALAlexandriaGEGenesys CapitalJDJDRF T1D Fund+4 more

Viamet provides a resource for people to organize questions and conduct research about medical travel, provider verification, care coordination, and health-related travel planning.

Digital HealthHealthtechTravel & HospitalityWellness & Fitness

Co-investorsASAstellas Venture Management LLCLILilly VenturesNONovartis Venture FundWOWoodford Investment Management

AgTechDurham, US

Tracy Jackson(Executive Officer)John Riley(Director)Joel Marcus(Director)John Dombrosky(Executive Officer, Director)

Co-investorsS2S2G Investments

Vital Plan sells herbal supplements and nutrient formulas aimed at supporting cellular health and overall wellness, including its RESTORE180 program for people managing chronic health challenges.

ConsumerDirect to ConsumerWellness & FitnessRaleigh, US

BRBraden Rawls(Executive Officer, Director)inDBDr. Bill Rawls(Co-founder)

BoardWalter Clarke(Director)

Co-investorsALAlumni VenturesCHCharlotte Angel FundTHThe Launch Place

Wesper offers an at-home sleep management system combining FDA-cleared home sleep apnea testing devices with logistics services such as dropship, remote patient monitoring, interpretation, and titration for sleep clinics and providers.

Digital HealthHealthtechMedical DevicesNew York, US

Amir Reuveny(Founder)Ahud Mordechai(Founder)

BoardSPSanto Politi(Director)in

Co-investorsABAbstract VenturesAPAphelion CapitalKRKrillion VenturesVAValor Equity PartnersBRBreyer CapitalCOCorrelation Ventures+1 more